II. Background
- Pregnancy Categories will be replaced on medication bottles with specific warnings and precautions by 2020 in U.S.
- http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425317.htm
 - Although FDA Pregnancy Categories are no longer listed, they are included here
- As of 2018, succinct guidance (to replace ABCDX) on specific drugs in pregnancy is lacking
 
 
 
III. Precautions: Pregnancy
- 
                          NSAIDs should generally be avoided in pregnancy (despite Category B before third trimester)
- Miscarriage risk in first trimester
 - Premature Ductus Arteriosus closure in third trimester
 - Second trimester use in second trimester had been considered safe until re-labeling in 2020
- Associated with fetal renal complications and oligohydramnios
 - New guidelines recommend avoiding after 20 weeks gestation
 - https://www.fda.gov/media/142967/download
 
 
 - 
                          Tramadol should be avoided in pregnancy
- Second trimester use may be safe
 - Fetal toxicity in animals (highest risk in first trimester)
 - Respiratory problems and withdrawal symptoms in newborn (avoid in third trimester)
 
 - 
                          Opioids should be avoided in pregnancy unless there is no viable alternative
- First trimester use is associated with heart defects and Neural Tube Defects (e.g. Spina bifida)
 - Late pregnancy use is associated with Opioid Withdrawal (neonatal abstinence syndrome)
- Neonatal Respiratory Distress may also occur
 
 - (2017) Presc Lett 24(11): 64
 - (2017) Obstet Gynecol 130(2):e81-e94 +PMID:28742676 [PubMed]
 - Reddy (2017) Obstet Gynecol 130(1):10-28 +PMID:28594753 [PubMed]
 
 
IV. Class B: No risk in controlled animal studies
- 
                          Acetaminophen (Tylenol)
- Analgesic of choice in pregnancy
 - May be associated with increased risk of ADHD in children with prolonged regular use (>4 to 6 weeks, esp. third trimester)
- However Acetaminophen association with ADHD is without evidence of causality
 - Cooper (2014) JAMA Pediatr 168(4):306-307 [PubMed]
 - Gou (2019) Aust N Z J Psychiatry 53(3): 195-206 [PubMed]
 - Matosich (2024) Am Fam Physician 109(1): 81-2 [PubMed]
 - Sznajder (2022) PLoS One 17(9): e0272593 [PubMed]
 
 
 - 
                          Opioids (Class D if prolonged use or high dose)
- Nalbuphine (Nubain)
 - Meperidine (Demerol)
 - Butorphanol (Stadol)
 - Fentanyl (Duragesic)
 - Hydromorphone (Dilaudid)
 - Methadone (Dolophine)
 - Morphine Sulfate
 - Oxycodone (Percocet)
 
 - NSAIDs (first and second trimester only, but see precaution above)
 
V. Class C: Small risk in controlled animal studies
- Opioids (Class D if prolonged use or high dose)
 - 
                          Barbiturates
- Butalbital (Fiorinal)
- Class D if prolonged use or high dose
 
 
 - Butalbital (Fiorinal)
 - NSAIDs (first or second trimester only)
 
VI. Class D: Strong evidence of risk to the human fetus
- 
                          Aspirin
                          
- Used only with specific indications in pregnancy
 - Risk of neonatal Hemorrhage, IUGR, perinatal death
 - Low dose Aspirin may be safer
 
 - All NSAIDs (Third Trimester)
 - Prolonged use or high dose of any Opioid
 - Prolonged use or high dose Butalbital (Fiorinal)
 - General Anesthesia - not in Briggs (1998)
 
VII. Preparations: Lactation Safe Analgesic Medications
- Acetaminophen (Tylenol)
 - Ibuprofen (Motrin)
 - 
                          Tramadol
                          
- Small amount crosses into Breast Milk
 
 
VIII. Preparations: Avoid Opioids in Lactation
- Opioids that are converted to active metabolites by CYP2D6
 - Risk of Overdose in babies if mother is a ultra-rapid CYP2D6 metabolizer
- Ultrarapid CYP2D6 metabolism occurs in 10% caucasians, 3% african americans, 1% chinese and hispanic
 
 - Preacutions if these Opioids are used in Lactation
- Avoid use beyond 4 days of life when milk intake increasing substantially
- Consider pumping and dumping while taking the Opioid
 - Transition to Acetaminophen or NSAID as soon as possible
 
 - Use the lowest effective dose of the shortest acting agent
 - Limit dosing to immediately after feeding
 
 - Avoid use beyond 4 days of life when milk intake increasing substantially
 
IX. References
- Briggs (1998) Drugs in Pregnancy and Lactation, 5th ed
 - (2012) Presc Lett 19(2): 11
 - Black (2003) Am Fam Physician 67(12):2517-24 [PubMed]
 - Larimore (2000) Prim Care 27(1):35-53 [PubMed]